Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats

Metabolism: Clinical and Experimental

Volumn 60, Issue 2, 2011, Pages 298-305

  Wang, Yanwen ^a,b   Campbell, Tony ^a   Perry, Benjamin ^a,b   Beaurepaire, Cécile ^a   Qin, Ling ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; BERBERINE; C REACTIVE PROTEIN; CHOLESTEROL; CITRIC ACID; GLUTATHIONE; INSULIN; LEPTIN; MALONALDEHYDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; FAT INTAKE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES;

ADIPONECTIN; ANIMALS; BERBERINE; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIETARY FATS; GLUCOSE TOLERANCE TEST; GLUTATHIONE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LEPTIN; LIVER; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78751647742     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.02.005     Document Type: Article

References (45)

1. Zhou J., Zhou S., Tang J., Zhang K., Guang L., and Huang Y. Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high- fat diet-induced diabetic rats Eur J Pharmacol 606 2009 262 268
2. Yi P., Lu F.E., Xu L.J., Chen G., Dong H., and Wang K.F. Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta World J Gastroenterol 14 2008 876 883
3. Cheng Z., Pang T., Gu M., Gao A.H., Xie C.M., and Li J.Y. Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK Biochim Biophys Acta 1760 2006 1682 1689
4. Hsieh Y.S., Kuo W.H., Lin T.W., Chang H.R., Lin T.H., and Chen P.N. Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells J Agric Food Chem 55 2007 10437 10445
5. Tang L.Q., Wei W., Chen L.M., and Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats J Ethnopharmacol 108 2006 109 115
6. Hwang J.M., Wang C.J., Chou F.P., Tseng T.H., Hsieh Y.S., and Lin W.L. Inhibitory effect of berberine on tert-butyl hydroperoxide-induced oxidative damage in rat liver Arch Toxicol 76 2002 664 670
7. Kim K.S., Rhee H.I., Park E.K., Jung K., Jeon H.J., and Kim J.H. Anti-inflammatory effects of Radix Gentianae Macrophyllae (Qinjiao), Rhizoma Coptidis (Huanglian) and Citri Unshiu Pericarpium (Wenzhou migan) in animal models Chin Med 3 2008 10
8. Jeong H.W., Hsu K.C., Lee J.W., Ham M., Huh J.Y., and Shin H.J. Berberine suppresses proinflammatory responses through AMPK activation in macrophages Am J Physiol Endocrinol Metab 296 2009 E955 E964
9. Cuellar M.J., Giner R.M., Recio M.C., Manez S., and Rios J.L. Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders Fitoterapia 72 2001 221 229
10. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ J Clin Endocrinol Metab 89 2004 2548 2556
11. Schmidt M.I., Duncan B.B., Vigo A., Pankow J.S., Couper D., and Ballantyne C.M. Leptin and incident type 2 diabetes: risk or protection? Diabetologia 49 2006 2086 2096
12. Diez J.J., and Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease Eur J Endocrinol 148 2003 293 300
13. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., and Vidal H. Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur Cytokine Netw 17 2006 4 12
14. Choi B.H., Ahn I.S., Kim Y.H., Park J.W., Lee S.Y., and Hyun C.K. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte Exp Mol Med 38 2006 599 605
15. Srinivasan K., Viswanad B., Asrat L., Kaul C.L., and Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacol Res 52 2005 313 320
16. Zhang M., Lv X.Y., Li J., Xu Z.G., and Chen L. The characterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model Exp Diabetes Res 704045 2008 2008
17. Tripathy D., Mohanty P., Dhindsa S., Syed T., Ghanim H., and Aljada A. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects Diabetes 52 2003 2882 2887
18. Huffman K.M., Shah S.H., Stevens R.D., Bain J.R., Muehlbauer M., and Slentz C.A. Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women Diabetes Care 32 2009 1678 1683
19. Kashyap S.R., Ioachimescu A.G., Gornik H.L., Gopan T., Davidson M.B., and Makdissi A. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL Obesity (Silver Spring) 2009
20. Belfort R., Mandarino L., Kashyap S., Wirfel K., Pratipanawatr T., and Berria R. Dose-response effect of elevated plasma free fatty acid on insulin signaling Diabetes 54 2005 1640 1648
21. Leng S.H., Lu F.E., and Xu L.J. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion Acta Pharmacol Sin 25 2004 496 502
22. Ward W.K., Beard J.C., Halter J.B., Pfeifer M.A., and Porte D. Jr Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus Diabetes Care 7 1984 491 502
23. Zhou L., Yang Y., Wang X., Liu S., Shang W., and Yuan G. Berberine stimulates glucose transport through a mechanism distinct from insulin Metabolism 56 2007 405 412
24. Chen Q.M., and Xie M.Z. Studies on the hypoglycemic effect of Coptis chinensis and berberine Yao Xue Xue Bao 21 1986 401 406
25. Gao C.R., Zhang J.Q., and Huang Q.L. Experimental study on berberine raised insulin sensitivity in insulin resistance rat models Zhongguo Zhong Xi Yi Jie He Za Zhi 17 1997 162 164
26. Lu S.S., Yu Y.L., Zhu H.J., Liu X.D., Liu L., and Liu Y.W. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin- induced diabetic rats J Endocrinol 200 2009 159 165
27. Kim S.H., Shin E.J., Kim E.D., Bayaraa T., Frost S.C., and Hyun C.K. Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes Biol Pharm Bull 30 2007 2120 2125
28. Ko B.S., Choi S.B., Park S.K., Jang J.S., Kim Y.E., and Park S. Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma Biol Pharm Bull 28 2005 1431 1437
29. Zander M., Madsbad S., Madsen J.L., and Holst J.J. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study Lancet 359 2002 824 830
30. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol Res 50 2001 537 546
31. Ar'Rajab A., and Ahren B. Long-term diabetogenic effect of streptozotocin in rats Pancreas 8 1993 50 57
32. Wang C., Li J., Lv X., Zhang M., Song Y., and Chen L. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin Eur J Pharmacol 620 2009 131 137
33. Zhou L., Wang X., Shao L., Yang Y., Shang W., and Yuan G. Berberine acutely inhibits insulin secretion from beta-cells through 3′,5′- cyclic adenosine 5′-monophosphate signaling pathway Endocrinology 149 2008 4510 4518
34. Wang Z.S., Lu F.E., Chen G., Xu L.J., Wang K.F., and Zou X. Effect of berberine on insulin secretion and glucokinase activity of NIT-1 cells Yao Xue Xue Bao 42 2007 1045 1049
35. Wang Z.Q., Lu F.E., Leng S.H., Fang X.S., Chen G., and Wang Z.S. Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity World J Gastroenterol 14 2008 6004 6011
36. Gu W., Zeng W.H., and Hu H.Y. Effects of berberine on adiponectin mRNA expression in 3T3-L1 adipocyte Zhongguo Zhong Yao Za Zhi 30 2005 286 288
37. Singh J., and Kakkar P. Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats J Ethnopharmacol 123 2009 22 26
38. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., and Chou C.J. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
39. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
40. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 25 2004 4 7
41. Lankas G.R., Leiting B., Roy R.S., Eiermann G.J., Beconi M.G., and Biftu T. Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9 Diabetes 54 2005 2988 2994
42. Yin J., Gao Z., Liu D., Liu Z., and Ye J. Berberine improves glucose metabolism through induction of glycolysis Am J Physiol Endocrinol Metab 294 2008 E148 E156
43. Kong W.J., Zhang H., Song D.Q., Xue R., Zhao W., and Wei J. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression Metabolism 58 2009 109 119
44. Wang Y.X., Wang Y.P., Zhang H., Kong W.J., Li Y.H., and Liu F. Synthesis and biological evaluation of berberine analogues as novel up-regulators for both low-density-lipoprotein receptor and insulin receptor Bioorg Med Chem Lett 19 2009 6004 6008
45. Zhang H., Wei J., Xue R., Wu J.D., Zhao W., and Wang Z.Z. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Metabolism 59 2009 285 292